88 related articles for article (PubMed ID: 6609251)
21. A comparison of cefamandole, cefoxitin, cefuroxime, cefotaxime and cefoperazone: an in vitro test on a number of beta-lactamase producing strains of 9 species and 1 genus of bacteria.
Kuipers JS
Curr Med Res Opin; 1981; 7(3):196-203. PubMed ID: 6971210
[TBL] [Abstract][Full Text] [Related]
22. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868
[TBL] [Abstract][Full Text] [Related]
23. [In vivo effects of cefoperazone in local infection].
Kumano K; Nishida N; Hayashi T; Kasuga C; Watanabe Y; Yasuda T; Saikawa I
Jpn J Antibiot; 1983 Dec; 36(12):3450-5. PubMed ID: 6325755
[TBL] [Abstract][Full Text] [Related]
24. In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.
Matsubara N; Minami S; Muraoka T; Saikawa I; Mitsuhashi S
Antimicrob Agents Chemother; 1979 Dec; 16(6):731-5. PubMed ID: 316988
[TBL] [Abstract][Full Text] [Related]
25. [Studies on sulbactam/cefoperazone in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
[TBL] [Abstract][Full Text] [Related]
26. [Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials (author's transl)].
Matsuoka A; Sumi K; Yoshimoto H; Takase M; Takashima S; Mimura K
Jpn J Antibiot; 1982 Apr; 35(4):993-1003. PubMed ID: 6285029
[TBL] [Abstract][Full Text] [Related]
27. [Antimicrobial activity of cefotiam against various clinical isolates from 1981 to 1985].
Matsuo K; Uete T
Jpn J Antibiot; 1986 Aug; 39(8):1981-7. PubMed ID: 3467078
[TBL] [Abstract][Full Text] [Related]
28. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
Jpn J Antibiot; 1991 Feb; 44(2):130-9. PubMed ID: 2041154
[TBL] [Abstract][Full Text] [Related]
29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
30. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
[TBL] [Abstract][Full Text] [Related]
31. [Beta-lactamase induction in Pseudomonas aeruginosa by cefpiramide and 3 other antipyocyanic cephalosporins].
Drigues P; Lanau C; Combes T; Roche G; Salhi A
Pathol Biol (Paris); 1986 May; 34(5):419-23. PubMed ID: 3095775
[TBL] [Abstract][Full Text] [Related]
32. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
Neu HC; Chin NX
Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
[TBL] [Abstract][Full Text] [Related]
33. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
[TBL] [Abstract][Full Text] [Related]
34. [Antibacterial activity of aztreonam against clinical isolates].
Igari J
Jpn J Antibiot; 1994 May; 47(5):502-20. PubMed ID: 8051793
[TBL] [Abstract][Full Text] [Related]
35. [Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].
Toyonaga Y; Kurosu Y; Nakamura H; Sugita M; Takahashi T; Hori M
Jpn J Antibiot; 1984 Dec; 37(12):2457-77. PubMed ID: 6098740
[TBL] [Abstract][Full Text] [Related]
36. [Antimicrobial susceptibility and beta-lactamase types among clinical isolates during January and February 2000 in the Kinki area of Japan].
Yamasaki K; Nishio H; Komatsu M; Satoh K; Yamashita T; Washidu R; Shimakawa K; Kinoshita S; Ura T; Aihara M
Jpn J Antibiot; 2002 Sep; 55 Suppl A():65-78. PubMed ID: 12599530
[TBL] [Abstract][Full Text] [Related]
37. [Drug sensitivity and beta-lactamase producibility of various types of bacteria clinically isolated during the period from December 1999 to February 2000].
Hashimoto K; Kinosita C; Yoshinaga H; Sonda Y; Itoyama T; Oyamada K; Kajimura K; Kondou M; Sagawa K; Ouno T; Kawamoto K; Souda K; Hara K; Kakihara M; Tanaka T; Ryutou M; Shichiji A; Nakashima K; Ishibashi K; Tabira R; Yamamoto S; Nishida M; Tsutsumi Y
Jpn J Antibiot; 2002 Sep; 55 Suppl A():86-94. PubMed ID: 12599532
[TBL] [Abstract][Full Text] [Related]
38. [Detection of beta-lactamase-producing strains isolated from urinary tract and their drug susceptibility].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Yamada Y; Nishikawa E
Hinyokika Kiyo; 1990 May; 36(5):569-75. PubMed ID: 2399858
[TBL] [Abstract][Full Text] [Related]
39. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
Okamoto R; Hara T; Yoshida T; Orikasa Y; Ogino H; Iwamatsu K; Inouye S
Drugs Exp Clin Res; 1990; 16(4):157-65. PubMed ID: 2127567
[TBL] [Abstract][Full Text] [Related]
40. [Fundamental and clinical studies of cefoperazone in children (author's transl)].
Yamaguchi H; Nishikawa K; Ogawa A; Kuno K; Kondo K
Jpn J Antibiot; 1980 Aug; 33(8):841-51. PubMed ID: 6451730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
